Eastwood Bio-Medical Canada Inc
XTSX:EBM

Watchlist Manager
Eastwood Bio-Medical Canada Inc Logo
Eastwood Bio-Medical Canada Inc
XTSX:EBM
Watchlist
Price: 0.64 CAD 10.34% Market Closed
Market Cap: 44.1m CAD

Net Margin

-69.3%
Current
Declining
by 11.9%
vs 3-y average of -57.4%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-69.3%
=
Net Income
CA$-411.8k
/
Revenue
CA$594.6k

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-69.3%
=
Net Income
CA$-411.8k
/
Revenue
CA$594.6k

Peer Comparison

Country Company Market Cap Net
Margin
CA
Eastwood Bio-Medical Canada Inc
XTSX:EBM
44.1m CAD
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
525.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
CH
Novartis AG
SIX:NOVN
220.9B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
271.6B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
148.4B USD
Loading...

Market Distribution

In line with most companies in Canada
Percentile
32nd
Based on 4 909 companies
32nd percentile
-69.3%
Low
-9 940 586.9% — -85.9%
Typical Range
-85.9% — 5.5%
High
5.5% — 60 777.6%
Distribution Statistics
Canada
Min -9 940 586.9%
30th Percentile -85.9%
Median -7.8%
70th Percentile 5.5%
Max 60 777.6%

Eastwood Bio-Medical Canada Inc
Glance View

Market Cap
44.1m CAD
Industry
Pharmaceuticals

Eastwood Bio-Medical Canada, Inc. is a natural health supplement distribution company. The company is headquartered in Richmond, British Columbia. The company went IPO on 2014-09-05. The firm is a licensed distributor of the Eleotin line of products, which include formulations based on natural ingredients. The Eleotin products include natural remedies for certain metabolic disorders such as blood glucose disorders, hypertension and obesity, and can be used as a dietary supplement. The firm's licensed products include Eleotin A 700, which is a treatment for spleen deficiency, lack of appetite and fatigue; Eleotin AL88, a laxative; Eleotin Cal20, for bone and teeth maintenance; Eleotin V3D for the development and maintenance of bones and teeth; Eleotin G2000 for cardiovascular health; Eleotin H55, a sedative and tension relief, Eleotin Zn330, which is involved in tissue formation and metabolism; Eleotin Bentley, which is used to promote healthy glucose levels, and Eleotin LBM, which is recommended for hypertension relief.

EBM Intrinsic Value
0.03 CAD
Overvaluation 95%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-69.3%
=
Net Income
CA$-411.8k
/
Revenue
CA$594.6k
What is Eastwood Bio-Medical Canada Inc's current Net Margin?

The current Net Margin for Eastwood Bio-Medical Canada Inc is -69.3%, which is below its 3-year median of -57.4%.

How has Net Margin changed over time?

Over the last 3 years, Eastwood Bio-Medical Canada Inc’s Net Margin has decreased from -11% to -69.3%. During this period, it reached a low of -74.5% on Apr 30, 2024 and a high of -11% on Jul 1, 2022.

Back to Top